These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Neisseria meningitidis B vaccines. Panatto D; Amicizia D; Lai PL; Gasparini R Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622 [TBL] [Abstract][Full Text] [Related]
7. [Neisseria meningitidis: new vaccines and preventive strategies]. Morciano L; Zaratti L; Franco E Ig Sanita Pubbl; 2012; 68(1):97-104. PubMed ID: 22507995 [TBL] [Abstract][Full Text] [Related]
8. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Poland GA Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016 [TBL] [Abstract][Full Text] [Related]
9. [Anti-meningococcal vaccines: diversity of vaccination policies and recommendations]. Gendrel D Arch Pediatr; 2012 Sep; 19 Suppl 2():S70-6. PubMed ID: 22883370 [TBL] [Abstract][Full Text] [Related]
10. Meningococcal disease: risk for international travellers and vaccine strategies. Wilder-Smith A Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105 [TBL] [Abstract][Full Text] [Related]
11. [Meningococcal disease in Africa--epidemiology and prevention]. Norheim G; Rosenqvist E; Aavitsland P; Caugant DA Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659 [TBL] [Abstract][Full Text] [Related]
12. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Trotter CL; Gay NJ; Edmunds WJ Am J Epidemiol; 2005 Jul; 162(1):89-100. PubMed ID: 15961591 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and meningococcal serogroup distribution in the United States. Hershey JH; Hitchcock W Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868 [No Abstract] [Full Text] [Related]
14. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. MacLennan J; Obaro S; Deeks J; Lake D; Elie C; Carlone G; Moxon ER; Greenwood B J Infect Dis; 2001 Jan; 183(1):97-104. PubMed ID: 11087205 [TBL] [Abstract][Full Text] [Related]
15. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults. Pace D Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685 [TBL] [Abstract][Full Text] [Related]
16. Challenges in immunisation against bacterial infection in children. Trück J; Pollard AJ Early Hum Dev; 2010 Nov; 86(11):695-701. PubMed ID: 20851537 [TBL] [Abstract][Full Text] [Related]
17. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned. Borrow R; Miller E Expert Rev Vaccines; 2006 Dec; 5(6):851-7. PubMed ID: 17184222 [TBL] [Abstract][Full Text] [Related]
18. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Soriano-Gabarró M; Wolter J; Hogea C; Vyse A Expert Rev Anti Infect Ther; 2011 Sep; 9(9):761-74. PubMed ID: 21905785 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450 [TBL] [Abstract][Full Text] [Related]
20. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines. Heyderman RS; Davenport V; Williams NA Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]